Shehnaaz Suliman
Director/Board Member at ULTRAGENYX PHARMACEUTICAL INC.
Net worth: 866 593 $ as of 2024-03-30
Profile
Shehnaaz Suliman is currently the Chief Executive Officer & Director at ReCode Therapeutics, Inc. She also serves as the Chairman at Executive Women in Bio.
In addition, she holds positions as an Independent Director at Ultragenyx Pharmaceutical, Inc. and 10X Genomics, Inc. Previously, she worked as a Director at Parvus Therapeutics, Inc. from 2017 to 2019.
Prior to that, she was the Vice President & Head-Global Therapeutic at Roche Holding AG from 2015 to 2017.
She also served as the Senior VP-Corporate Development & Strategy at Theravance Biopharma, Inc. from 2017 to 2019.
From 2021 to 2022, she was the Chief Operating & Business Officer at Alector, Inc. Dr. Suliman obtained a graduate degree and an MBA from the University of Oxford.
She also holds an undergraduate degree and a doctorate from the University of Cape Town.
Additionally, she earned an MBA from Saïd Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-06-06 | 14,855 ( 0.02% ) | 693 580 $ | 2024-03-30 | |
10X GENOMICS INC CLASS A
0.00% | 2023-06-13 | 4,610 ( 0.00% ) | 173 013 $ | 2024-03-30 |
Shehnaaz Suliman active positions
Companies | Position | Start |
---|---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Director/Board Member | 2019-01-29 |
10X GENOMICS, INC. | Director/Board Member | 2019-07-31 |
Executive Women in Bio
Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development. | Chairman | - |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Chief Executive Officer | 2022-01-10 |
Former positions of Shehnaaz Suliman
Companies | Position | End |
---|---|---|
ALECTOR, INC. | Chief Executive Officer | 2021-12-14 |
Parvus Therapeutics, Inc.
Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Director/Board Member | 2019-06-30 |
THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 2019-03-30 |
ROCHE HOLDING AG | Corporate Officer/Principal | 2017-06-30 |
Training of Shehnaaz Suliman
University of Oxford | Graduate Degree |
University of Cape Town | Doctorate Degree |
Saïd Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
ROCHE HOLDING AG | Health Technology |
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
10X GENOMICS, INC. | Health Technology |
THERAVANCE BIOPHARMA, INC. | Health Technology |
ALECTOR, INC. | Health Technology |
Private companies | 3 |
---|---|
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Health Technology |
Parvus Therapeutics, Inc.
Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Health Technology |
Executive Women in Bio
Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development. | Commercial Services |
- Stock Market
- Insiders
- Shehnaaz Suliman